It was a couple of years ago now I was warned about my blood sugar being too high. Eventually, after two successive high ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Abbott , the global leader in continuous glucose monitoring (CGM) biowearable technology1, today announced that it has entered a first-of-its-kind agreement to integrate data from its world-leading1 ...

Continuous glucose monitoring (CGM) devices may overestimate ... A CGM device (Abbott Freestyle Libre 2) and the standard finger-prick test for capillary blood glucose. Participants — nine ...

Future Market Insights (FMI) has revealed an insightful new report showcasing the remarkable growth trajectory of the global patient monitoring devices market. Valued at USD 46.4 million in 2022, the ...

AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 ...

Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of ...

In a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS ...

Medical device maker Abbott Laboratories maintained its annual profit forecast on Wednesday and said it expected the U.S. tariffs to hit earnings by a "few hundred million dollars".

An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type ...

Personal continuous glucose monitors are accurate at measuring glucose levels in most ranges for hospitalized patients with ...